Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 5:54 AM ET

Healthcare Equipment and Supplies

Company Overview of Verinata Health, Inc.

Company Overview

Verinata Health, Inc. develops non-invasive tests for the early identification of fetal chromosomal abnormalities. It develops non-invasive alternatives for maternal and fetal health; and non-invasive verifi prenatal tests to detect Turner syndromes. The company has a strategic agreement with PerkinElmer Inc. Verinata Health, Inc. was formerly known as Artemis Health, Inc. and changed its name to Verinata Health, Inc. in April, 2011. The company was founded in 2002 and is based in Redwood City, California. As of February 21, 2013, Verinata Health, Inc. operates as a subsidiary of Illumina Inc.

800 Saginaw Drive

Redwood City, CA 94063

United States

Founded in 2002





Key Executives for Verinata Health, Inc.

Executive Chairman, Chief Executive Officer, and Director
Age: 54
Vice President of Finance and Administration
Senior Vice President of Research and Development
Vice President of CLIA Lab Operations
Compensation as of Fiscal Year 2015.

Verinata Health, Inc. Key Developments

Illumina, Inc. and Sequenom, Inc. Agree to Settle All Pending Infringement Claims and Other Disputes Between Sequenom and Verinata Health, Inc

Illumina Inc. and Sequenom Inc. announced they have agreed to settle all pending infringement claims and other disputes between Sequenom and Verinata Health Inc. The parties will pool their owned and in-licensed intellectual property directed to noninvasive prenatal testing (NIPT), including patents that will remain the subject of ongoing interference proceedings. Under the agreement, Illumina will have exclusive worldwide rights to utilize the pooled intellectual property to develop and sell in-vitro diagnostic kits for NIPT and to license third-party laboratories wishing to develop and sell their own laboratory-developed NIPT tests under the collection of pooled patents. In addition, Sequenom and Illumina will each have rights to utilize all pooled patents to develop and sell their own respective laboratory-developed NIPT tests. The parties will share the revenue from the patent pool and Illumina will pay Sequenom a royalty on sales of in-vitro diagnostic kits for NIPT. Illumina will make a $50 million upfront payment to Sequenom as part of the overall agreement, as well as certain ongoing commitments for payments to Sequenom from the patent pool structure through 2020.

Similar Private Companies By Industry

Company Name Region
Sun Biomedical Laboratories, Inc. United States
Neurowave Medical Technologies LLC United States
Rinovum Women's Health, Inc. United States
Relucent Solutions LLC United States
PhotoMedex Technology, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Verinata Health, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at